ATHE ææ°ååæã®æ±ºç®å ±åæž
çºè¡šæ¥8/28/2026
EPSå®çžŸïŒUSDïŒ-0.90
売äžé«å®çžŸïŒUSDïŒ1.16M
Alterity Therapeutics Ltdã®æ±ºç®æ¥ã»å ±åæž
ãã®ããŒãžã§ã¯ãææ°ã® Alterity Therapeutics Ltd ã®æ±ºç®å ±åæžã次å Alterity Therapeutics Ltd ã®æ±ºç®äºå®æ¥ãéå»ã®ããŒã¿ãAlterity Therapeutics Ltd ã®æ±ºç®é»è©±äŒè°ãã¥ãŒã¹ãªã©ã詳现㪠Alterity Therapeutics Ltd ã®æ±ºç®ããŒã¿ãæäŸããŠããŸãã
ATHE 次åååæã®æ±ºç®çºè¡šæ¥
çºè¡šæ¥--
EPSäºæ³ïŒUSDïŒ--
売äžé«äºæ³ïŒUSDïŒ--
ATHE FY2026 決ç®
EPS (å幎åææ¯)-0.90-22.42%
売äžé« (å幎åææ¯)1.16M302.63%
Alterity Therapeutics LtdïŒATHEïŒã®æ±ºç®å±¥æŽ
| å ¬éæ¥ | 察象æéçµäº | EPS/äºæž¬ | åç/äºæž¬ | EPSãµãã©ã€ãº % | 売äžé«ãµãã©ã€ãº % |
|---|---|---|---|---|---|
| -- | 2026H1 | --/-- | 596.04K/2.13M | -- | -72.08% |
| -- | 2025H1 | -0.55/-0.53 | 73.51K/1.15M | -3.49% | -93.62% |
| -- | 2025H2 | -0.00/-0.43 | --/-- | 98.86% | -- |
| -- | 2024H1 | --/-- | 77.27K/955.86K | -- | -91.92% |
| -- | 2024H2 | --/-- | 98.78K/907.87K | -- | -89.12% |
| -- | 2023H2 | --/-- | 3.42K/1.50M | -- | -99.77% |
| -- | 2023H1 | --/-- | 7.62K/-- | -- | -- |
| -- | 2022H1 | --/-- | 987.32/-- | -- | -- |